Shanghai Aladdin Biochemical Technology Co.,Ltd. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was CNY 182.41 million compared to CNY 174.71 million a year ago. Revenue was CNY 185.45 million compared to CNY 177.34 million a year ago.

Net income was CNY 30.91 million compared to CNY 50.26 million a year ago. Basic earnings per share from continuing operations was CNY 0.16 compared to CNY 0.25 a year ago. Diluted earnings per share from continuing operations was CNY 0.16 compared to CNY 0.25 a year ago.